These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 13781940)

  • 1. [Preliminary results with armin (ethyl-ethoxy phosphoryl p-nitrophenolate) in myasthenia gravis].
    VOJVODIC V; GRBESA B; STEVANOVIC M; BINENFELD Z; GAZIVODA N; BARYLA K; BOZIC V
    Vojnosanit Pregl; 1960 Nov; 17():1167-70. PubMed ID: 13781940
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of Armin for stimulation of labor activity].
    BELIAEVA EA; CHAIKOVSKAIA AL
    Kazan Med Zh; 1962; 1():58-60. PubMed ID: 13866745
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of armin in glaucoma].
    VEDENEEVA VI
    Tr Leningr Sanitarnogig Med Inst; 1960; 57():108-9. PubMed ID: 13780545
    [No Abstract]   [Full Text] [Related]  

  • 4. [EFFECT OF THE MODE OF ADMINISTRATION AND THE SEX OF ALBINO RATS ON THE ACUTE TOXICITY OF ETHYL-ETHOXY-PHOSPHORYL-P-NITROPHENOLATE (ARMIN)].
    LIKAR D
    Vojnosanit Pregl; 1963 Dec; 20():746-51. PubMed ID: 14125760
    [No Abstract]   [Full Text] [Related]  

  • 5. [Enzymatic destruction of Armine (ethyl-ethoxyphosphoryl p-nitrophenolate) in the human plasma].
    BINENFELD Z
    Vojnosanit Pregl; 1962 Feb; 19():128-9. PubMed ID: 13968324
    [No Abstract]   [Full Text] [Related]  

  • 6. [On anti-myasthenic activity of an oxamide derivative (Win 8077)].
    GENTILI C; LOPERFIDO E
    Arch Ital Sci Farmacol; 1959 Oct; 9():517-28. PubMed ID: 13827329
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic value of new antimyasthenia drugs according to clinical and electromyographic aspects].
    EMERYK B; BIEZANSKI W
    Neurol Neurochir Psychiatr Pol; 1959; 9():471-83. PubMed ID: 13820172
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies in myasthenia gravis; preliminary report on therapy with mestinon bromide.
    OSSERMAN KE; TENG P; KAPLAN LI
    J Am Med Assoc; 1954 Jul; 155(11):961-5. PubMed ID: 13162833
    [No Abstract]   [Full Text] [Related]  

  • 9. [New drug in the treatment of myasthenia gravis].
    GRAVEL H; BEAUREGARD JM
    Union Med Can; 1956 Jun; 85(6):681-5. PubMed ID: 13337985
    [No Abstract]   [Full Text] [Related]  

  • 10. Pyridostigmin (mestinon) in the treatment of myasthenia gravis.
    SCHWAB RS; TIMBERLAKE WH
    N Engl J Med; 1954 Aug; 251(7):271-2. PubMed ID: 13185412
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of 3-hydroxy phenyl-dimethylethylammonium chloride (tensilon) in myasthenia gravis.
    WESTERBERG MR; MAGEE KR; SHIDEMAN FE
    Med Bull (Ann Arbor); 1951 Sep; 17(9):311-6. PubMed ID: 14893613
    [No Abstract]   [Full Text] [Related]  

  • 12. [A new drug for myasthenia gravis].
    RAVINA A
    Presse Med (1893); 1955 Oct; 63(65):1329. PubMed ID: 13280621
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of myasthenia gravis with pyridostigmine (mestinon)].
    BARRAQUER-BORDAS L; PONCESVERGE J
    Rev Clin Esp; 1955 Aug; 58(4):236-43. PubMed ID: 13281050
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mestinon, a new remedy for myasthenia gravis].
    LONNUM A
    Tidsskr Nor Laegeforen; 1955 Aug; 75(16):581-2. PubMed ID: 13267868
    [No Abstract]   [Full Text] [Related]  

  • 15. Mestinon in the treatment of myasthenia gravis.
    WESTERBERG MR; MAGEE KR
    Neurology; 1954 Oct; 4(10):762-72. PubMed ID: 13214277
    [No Abstract]   [Full Text] [Related]  

  • 16. Report of a case of myasthenia gravis.
    BRYAN FA
    J Indiana State Med Assoc; 1956 Mar; 49(3):257-8. PubMed ID: 13306994
    [No Abstract]   [Full Text] [Related]  

  • 17. MYASTHENIA gravis.
    Br Med J; 1956 Jun; 1(4978):1283-4. PubMed ID: 13316135
    [No Abstract]   [Full Text] [Related]  

  • 18. Pyridostigmine (mestinon) in myasthenia gravis; a case report.
    POLLITZER RS
    J S C Med Assoc; 1956 Feb; 52(2):46-7. PubMed ID: 13286785
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of myasthenia gravis with prolonged-action mestinon.
    MAGEE KR; WESTERBERG MR
    Neurology; 1959 May; 9(5):348-51. PubMed ID: 13657293
    [No Abstract]   [Full Text] [Related]  

  • 20. Mestinon (pyridostigmine bromide) in myasthenia gravis.
    SCHWARZ H
    Can Med Assoc J; 1956 Jul; 75(2):98-100. PubMed ID: 13343058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.